GRI Bio Etf Forward View - Relative Strength Index
| GRI Etf | USD 2.84 0.42 12.88% |
GRI Etf outlook is based on your current time horizon. We suggest always using this module together with an analysis of GRI Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of GRI Bio's share price is below 30 as of 2nd of February 2026. This usually indicates that the etf is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling GRI Bio, making its price go up or down. Momentum 28
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (1.07) | EPS Estimate Current Year (48.86) | EPS Estimate Next Year (12.60) | Wall Street Target Price 643.9998 | EPS Estimate Current Quarter (1.11) |
Using GRI Bio hype-based prediction, you can estimate the value of GRI Bio from the perspective of GRI Bio response to recently generated media hype and the effects of current headlines on its competitors.
GRI Bio after-hype prediction price | USD 2.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of GRI Bio to cross-verify your projections. GRI Bio Additional Predictive Modules
Most predictive techniques to examine GRI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GRI using various technical indicators. When you analyze GRI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 28.84 | 28.84 |
| Check GRI Bio Volatility | Backtest GRI Bio | Information Ratio |
GRI Bio Trading Date Momentum
| On February 02 2026 GRI Bio was traded for 2.84 at the closing time. Highest GRI Bio's price during the trading hours was 3.61 and the lowest price during the day was 2.84 . There was no trading activity during the period 0.0. Lack of trading volume on the 2nd of February did not cause price change. The overall trading delta to current price is 14.79% . |
| Compare GRI Bio to competition |
Other Forecasting Options for GRI Bio
For every potential investor in GRI, whether a beginner or expert, GRI Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GRI Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GRI. Basic forecasting techniques help filter out the noise by identifying GRI Bio's price trends.GRI Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GRI Bio etf to make a market-neutral strategy. Peer analysis of GRI Bio could also be used in its relative valuation, which is a method of valuing GRI Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GRI Bio Market Strength Events
Market strength indicators help investors to evaluate how GRI Bio etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GRI Bio shares will generate the highest return on investment. By undertsting and applying GRI Bio etf market strength indicators, traders can identify GRI Bio entry and exit signals to maximize returns.
GRI Bio Risk Indicators
The analysis of GRI Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GRI Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gri etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.57 | |||
| Standard Deviation | 11.25 | |||
| Variance | 126.51 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for GRI Bio
The number of cover stories for GRI Bio depends on current market conditions and GRI Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GRI Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GRI Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.